Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Humbert

Showing results (281-290 of 958) with videos related to

Pageof 96
Sort By:
Proceedings of the American Thoracic Society|October 3, 2012
Clinical year in review IV: HIV, mycobacterial disease, pulmonary hypertension, and interstitial lung diseaseHarold R Collard, Alison Morris, Charles L Daley, et al.
European Heart Journal|February 1, 2023
The 'Ten Commandments' of the 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertensionStephan Rosenkranz, Marion Delcroix, George Giannakoulas, et al.
AIDS (London, England)|July 2, 2005
Human herpes virus 8 in HIV and non-HIV infected patients with pulmonary arterial hypertension in FranceDavid Montani, Anne-Genevieve Marcelin, Olivier Sitbon, et al.
Clinical Reviews in Allergy & Immunology|January 12, 2010
Scleroderma lung diseaseJérôme Le Pavec, David Launay, Stephen C Mathai, et al.
La Revue Du Praticien|January 16, 2009
[Pulmonary arterial hypertension associated with common diseases: connective-tissue diseases, HIV infection and portal hypertension]Olivier Sitbon, Xavier Jaïs, Jérôme Le Pavec, et al.
Journal of Asthma and Allergy|September 30, 2021
Omalizumab Effectiveness in Severe Allergic Asthma with Multiple Allergic Comorbidities: A Post-Hoc Analysis of the STELLAIR StudyJocelyne Just, Celine Thonnelier, Melisande Bourgoin-Heck, et al.
Circulation|September 23, 2015
Response to Letter Regarding Article, "Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension"Edmund M T Lau, David Montani, Xavier Jaïs, et al.
Gastroenterology|January 13, 2006
Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertensionSteeve Provencher, Philippe Herve, Xavier Jais, et al.
Radiology|February 28, 2002
Pulmonary arterial hypertension: thin-section CT predictors of epoprostenol therapy failureArnaud Resten, Sophie Maître, Marc Humbert, et al.
American Journal of Respiratory and Critical Care Medicine|October 26, 2020
Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?Jason Weatherald, Athénaïs Boucly, Laurent Savale, et al.
Pageof 96

Showing results (281-290 of 958) with videos related to

Sort By:
Pageof 96
Proceedings of the American Thoracic Society|October 3, 2012
Clinical year in review IV: HIV, mycobacterial disease, pulmonary hypertension, and interstitial lung diseaseHarold R Collard, Alison Morris, Charles L Daley, et al.
European Heart Journal|February 1, 2023
The 'Ten Commandments' of the 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertensionStephan Rosenkranz, Marion Delcroix, George Giannakoulas, et al.
AIDS (London, England)|July 2, 2005
Human herpes virus 8 in HIV and non-HIV infected patients with pulmonary arterial hypertension in FranceDavid Montani, Anne-Genevieve Marcelin, Olivier Sitbon, et al.
Clinical Reviews in Allergy & Immunology|January 12, 2010
Scleroderma lung diseaseJérôme Le Pavec, David Launay, Stephen C Mathai, et al.
La Revue Du Praticien|January 16, 2009
[Pulmonary arterial hypertension associated with common diseases: connective-tissue diseases, HIV infection and portal hypertension]Olivier Sitbon, Xavier Jaïs, Jérôme Le Pavec, et al.
Journal of Asthma and Allergy|September 30, 2021
Omalizumab Effectiveness in Severe Allergic Asthma with Multiple Allergic Comorbidities: A Post-Hoc Analysis of the STELLAIR StudyJocelyne Just, Celine Thonnelier, Melisande Bourgoin-Heck, et al.
Circulation|September 23, 2015
Response to Letter Regarding Article, "Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension"Edmund M T Lau, David Montani, Xavier Jaïs, et al.
Gastroenterology|January 13, 2006
Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertensionSteeve Provencher, Philippe Herve, Xavier Jais, et al.
Radiology|February 28, 2002
Pulmonary arterial hypertension: thin-section CT predictors of epoprostenol therapy failureArnaud Resten, Sophie Maître, Marc Humbert, et al.
American Journal of Respiratory and Critical Care Medicine|October 26, 2020
Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?Jason Weatherald, Athénaïs Boucly, Laurent Savale, et al.
Pageof 96